Elevated PAPP-A sets alarm bells ringing in patients with cardiac chest pain

Goran Loncar1, Stephan von Haehling

  • 1Cardiology Department, Zvezdara University Medical Center, Belgrade, Serbia.

Insights

Elevated pregnancy-associated plasma protein A (PAPP-A) levels in cardiac chest pain patients signal a fivefold increased risk of adverse cardiovascular events within 90 days. This novel marker offers prognostic value beyond traditional risk factors.

Area of Science:

  • Cardiovascular Research
  • Biochemical Markers
  • Prognostic Indicators

Background:

  • Novel biochemical markers are crucial for refining risk assessment in patients prone to adverse cardiac events.
  • Pregnancy-associated plasma protein A (PAPP-A) is emerging as a significant prognostic marker, independent of conventional risk factors.
  • PAPP-A is increasingly recognized for its role in indicating plaque destabilization within cardiovascular research.

Discussion:

  • Higher serum PAPP-A levels (>34.6 mIU/l) in cardiac chest pain patients are independently linked to a significantly increased short-term risk of cardiovascular events.
  • These events include myocardial infarction, ischemic stroke, stent thrombosis, and cardiovascular-related death within 90 days.
  • Patients with PAPP-A levels above the threshold face a fivefold higher frequency of adverse cardiovascular events compared to those with lower levels.

Key Insights:

  • Serum PAPP-A >34.6 mIU/l serves as a critical warning for heightened short-term cardiovascular event risk in chest pain patients.
  • The prognostic information provided by PAPP-A is independent of traditional cardiovascular risk factors.
  • A hazard ratio of 5.28 (95% CI: 3.81-7.31) underscores the substantial risk associated with elevated PAPP-A levels.

Outlook:

  • Current evidence does not support PAPP-A as a diagnostic tool for acute coronary syndrome, especially when compared to troponin.
  • PAPP-A's interaction with heparin may limit its practical clinical application.
  • Further large-scale, multicenter studies are essential to validate PAPP-A's utility in routine clinical practice for cardiovascular risk stratification.

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
481
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
633
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Assessment of apical pulse01:17

Assessment of apical pulse

Assessing the Apical Pulse
Assessing the apical pulse is a critical nursing procedure, particularly indicated for:
2.8K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
565